Navigation Links
Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Date:3/13/2008

lated to a $1,726,000 increase in foreign exchange losses, due to the strength of the Canadian dollar against the U.S. dollar, and to $844,000 of restructuring expenses incurred in 2007. These two factors were partially offset in 2007 by an increase in interest income of $433,000 relating to the completion of the Company's two equity offerings, which generated gross proceeds of $24,807,000.

Nventa also reported a net loss of $2,319,000, or $0.01 per share, for the three months ended December 31, 2007, compared to a net loss of $2,043,000, or $0.02 per share, for the fourth quarter of 2006. The $276,000 increase in the net loss in the fourth quarter of 2007, compared to 2006, is principally related to a $200,000 increase in foreign exchange losses and to restructuring expenses incurred during 2007. These expense increases were partially offset by an increase in interest income of $124,000 during the fourth quarter of 2007, as a result of receiving the proceeds from the Company's two public equity offerings in 2007.

The Company had cash and cash equivalents of $12,859,000 as of December 31, 2007, compared to $2,972,000, as of December 31, 2006.

About New HspE7

The Company's lead candidate, new HspE7 (HspE7 + Poly-ICLC), is a novel therapeutic candidate intended for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. New HspE7 contains the novel CoVal(TM) fusion protein, HspE7 co-administered with the adjuvant Poly-ICLC, a toll-like receptor-3 (TLR3) agonist. An adjuvant is a substance added to vaccines to improve immune responses against target antigens. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune responses to the target antigens. Nventa is developing new HspE7 for multiple indicat
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
2. Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
3. Nventa updates progress of cervical dysplasia trial with new HspE7
4. Nventas CEO to present at two upcoming investor conferences
5. Nventa announces publication of HspE7 data
6. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
7. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
8. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Regenestem Network has announced ... in Buenos Aires, Argentina. The clinic will be lead ... Pastrana has assembled a multidisciplinary team of medical professionals ... state-of-the-art Puerto Madero office. , The new Regenestem ... IV clinical studies in cellular therapies, and establish Regenestem ...
(Date:5/26/2015)... Innovacyn, a leader in developing ... and animal health industries, announced today the recipients ... Agriculture College Scholarship Award. The scholarship was open ... passionate commitment to the agriculture industry through academic ... Alexis Pedrow from Anderson County Jr/Sr High School ...
(Date:5/26/2015)... and HILDEN, Germany , ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... QIAGEN Clinical Insight ® (QCI™) bioinformatics content ... interpret and report on genomic variants identified in ... for the bioinformatics platform are in oncology, for ...
(Date:5/26/2015)... May 26, 2015   Intrexon Corporation (NYSE: ... Gregory Frost , Ph.D., Senior Vice President and Head ... Global Healthcare Conference on Wednesday, June 3 rd , at ... New York City . About Intrexon ... Powering the Bioindustrial Revolution with Better DNA ™ to ...
Breaking Biology Technology:Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 2Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2
... Strategic Development of the Company,s National Network of ... Healthplace America, the country,s first and only ... services of Robert A. Yungk as Chief Strategy ... ensuring the company,s participating Healthplace Surgery Benefit(TM) providers ...
... exclusive access to, the global ... Biosystems Inc. (MBX:TSX) announced today that the Company ... based on discoveries arising from its extensive work ... The new technology represents a significant departure from ...
... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... CSKI ), a,leading fully integrated pharmaceutical company producing,over-the-counter ... today,announced that an extension notification filed with the ... Form 10-K on March 31, 2009, is,related to ...
Cached Biology Technology:Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer 2Microbix Announces A New Technology Platform For The SST Project 2Microbix Announces A New Technology Platform For The SST Project 3China Sky One Medical, Inc. Provides Update on Filing Form 10-K 2China Sky One Medical, Inc. Provides Update on Filing Form 10-K 3
(Date:5/10/2015)... Fingerprint Cards (FPC) has received an ... the distributor World Peace Industrial Group (WPI), part of WPG ... Asia . Deliveries are planned to take place during ... manufacturers in China . The order value ... of + 1 000 MSEK for 2015.   Jörgen ...
(Date:5/6/2015)... May 6, 2015 LifeBEAM, a developer of ... producer, announced today that they will expand their partnership ... first bio-sensing cycling helmet and the first joint project ... new colors in order to give cyclists more style ... addition, LifeBEAM and Lazer announced their plan to release ...
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... of millipede was recently discovered by a Northern Arizona ... researcher. , J. Judson Wynne, with the Department ... with the U.S. Geological Survey's Southwest Biological Center, and ... of Land Management (BLM), collected specimens leading to the ...
... a one-two punch to newts, according to biologists, who ... in amphibians. , The findings could also lead to ... malaria, chagas disease and sleeping sickness. All these diseases ... disease from one animal to another. , ...
... how it avoids ending up in a state of chaos, ... lead to epileptic fits. Scientists at Karolinska Institutet have now ... neuronal activity in check. , The human brain consists ... around ten billion contact junctions called synapses. The activity of ...
Cached Biology News:Discovery of new cave millipedes casts light on Arizona cave ecology 2Discovery of new cave millipedes casts light on Arizona cave ecology 3Leeches ferry infection among newts 2Rare cell prevents rampant brain activity 2
... software with the DeCypher Engine accelerator cards to ... perform searches like these from your desktop: ... under 6 days Align BAC-sized queries ... HMM analysis to compare 100,000 sequences to PFAM ...
... 200 series of microplate readers combines reagent ... in an affordable, easy-to-use platform for the ... unique modular design and adaptability of the ... choice of a monochromator (M200) or filter ...
Determin interaction of your protein with Echelons lipids...
Recommended fro Western blotting application...
Biology Products: